Research output per year
Research output per year
Personal profile
Headline
SENIOR FACULTY | Medicine, Hematology and Medical Oncology
Fingerprint
Dive into the research topics where Deirdre Cohen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Antibiotic treatment and survival in patients with resected, early-stage pancreatic ductal adenocarcinoma receiving chemotherapy
Gong, E., Fulop, D. J., Serebrenik, J., Labiner, A. J., Cohen, D. J., Sigel, K. M. & Lucas, A. L., 1 Apr 2025, In: JNCI Cancer Spectrum. 9, 2, pkaf024.Research output: Contribution to journal › Article › peer-review
Open Access -
A Phase 1b study of the OxPhos inhibitor ME-344 with bevacizumab in refractory metastatic colorectal cancer
Boland, P. M., Lenz, H. J., Ciombor, K. K., Florou, V., Pishvaian, M. J., Cusnir, M., Cohen, D., Guo, J. Y., Tang, M., Rajagopalan, P., Wiley, S. E., Ghalie, R. G. & Hochster, H. S., Feb 2025, In: Investigational New Drugs. 43, 1, p. 60-68 9 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study
on behalf of the LEAP-015 Investigators, 2025, (Accepted/In press) In: Journal of Clinical Oncology. 00748.Research output: Contribution to journal › Article › peer-review
-
Combining antivascular endothelial growth factor and anti-epidermal growth factor receptor antibodies: randomized phase II study of irinotecan and cetuximab with/without ramucirumab in second-line colorectal cancer (ECOG-ACRIN E7208)
Hochster, H. S., Catalano, P., Weitz, M., Mitchell, E. P., Cohen, D., O'dwyer, P. J., Faller, B. A., Kortmansky, J. S., O'hara, M. H., Kricher, S. M., Lacy, J., Lenz, H. J., Verma, U. & Benson, A. B., 1 Sep 2024, In: Journal of the National Cancer Institute. 116, 9, p. 1487-1494 8 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Retraction: CD44 Expression Denotes a Subpopulation of Gastric Cancer Cells in Which Hedgehog Signaling Promotes Chemotherapy Resistance
Yoon, C., Park, D. J., Schmidt, B., Thomas, N. J., Lee, H. J., Kim, T. S., Janjigian, Y. Y., Cohen, D. J. & Yoon, S. S., 15 Oct 2024, In: Clinical Cancer Research. 30, 20, p. 4803 1 p.Research output: Contribution to journal › Comment/debate
Open Access
Press/Media
-
Nimotuzumab plus gemcitabine prolongs survival in KRAS wild-type pancreatic cancer
3/06/22
1 item of Media coverage
Press/Media
-
Mount Sinai Receives Grant to Enhance Patient-Centric, Team-Based Pancreatic Cancer Care.
Goodman, K., Cohen, D. & Labow, D.
19/04/22 → 21/04/22
2 items of Media coverage
Press/Media
-
Mount Sinai Receives Grant to Enhance Patient-Centric, Team-Based Pancreatic Cancer Care
Goodman, K., Cohen, D. & Labow, D.
20/04/22
1 item of Media coverage
Press/Media